Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-14 6:57 pm Purchase |
2025-04-07 | 13G | DBV Technologies S.A. DBVT |
Citadel Advisors LLC | 9,194,107 6.400% |
9,194,107 (New Position) |
Filing History |
| 2025-02-24 5:55 pm Purchase |
2025-02-14 | 13G | Aardvark Therapeutics, Inc. Common Stock AARD |
Citadel Advisors LLC | 1,192,971 5.600% |
1,192,971 (New Position) |
Filing History |
| 2025-02-19 4:50 pm Purchase |
2025-02-11 | 13G | Sun Country Airlines Holdings, Inc. SNCY |
Citadel Advisors LLC | 3,196,914 6.100% |
3,196,914 (New Position) |
Filing History |
| 2025-02-14 6:32 pm Sale |
2024-12-31 | 13G | COMPASS Pathways plc CMPS |
Citadel Advisors LLC | 1,166,576 1.700% |
-4,268,100 (-78.53%) |
Filing History |
| 2025-02-14 6:25 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Citadel Advisors LLC | 3,465,307 4.100% |
54,543 (+1.60%) |
Filing History |
| 2025-02-14 6:24 pm Purchase |
2024-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Citadel Advisors LLC | 1,627,734 4.700% |
414,602 (+34.18%) |
Filing History |
| 2025-02-14 6:22 pm Sale |
2024-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Citadel Advisors LLC | 21,083 0.000% |
-4,265,844 (-99.51%) |
Filing History |
| 2025-02-14 6:20 pm Sale |
2024-12-31 | 13G | Korro Bio, Inc. KRRO |
Citadel Advisors LLC | 369,733 3.900% |
-159,518 (-30.14%) |
Filing History |
| 2025-02-14 6:18 pm Sale |
2024-12-31 | 13G | Hawaiian Electric Industries, Inc. HE |
Citadel Advisors LLC | 643,461 0.400% |
-8,206,776 (-92.73%) |
Filing History |
| 2025-02-14 6:13 pm Sale |
2024-12-31 | 13G | Acelyrin, Inc. SLRN |
Citadel Advisors LLC | 4,218,748 4.200% |
-2,430,694 (-36.55%) |
Filing History |
| 2025-02-14 5:24 pm Unchanged |
2025-01-23 | 13G | Arvinas, Inc. ARVN |
Citadel Advisors LLC | 3,480,125 5.100% |
0 (Unchanged) |
Filing History |
| 2025-01-30 4:09 pm Purchase |
2025-01-23 | 13G | Arvinas, Inc. ARVN |
Citadel Advisors LLC | 3,480,125 5.100% |
3,480,125 (New Position) |
Filing History |
| 2024-12-13 5:02 pm Purchase |
2024-12-06 | 13G | Nkarta, Inc. NKTX |
Citadel Advisors LLC | 3,819,867 5.400% |
3,819,867 (New Position) |
Filing History |
| 2024-11-14 4:24 pm Sale |
2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN |
Citadel Advisors LLC | 1,734,094 3.700% |
-660,354 (-27.58%) |
Filing History |
| 2024-11-14 4:23 pm Sale |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,960,081 3.000% |
-112,506 (-3.66%) |
Filing History |
| 2024-11-14 4:21 pm Sale |
2024-09-30 | 13G | Dutch Bros Inc. BROS |
Citadel Advisors LLC | 2,974,719 2.600% |
-1,099,167 (-26.98%) |
Filing History |
| 2024-11-14 4:20 pm Purchase |
2024-09-30 | 13G | COMPASS Pathways plc CMPS |
Citadel Advisors LLC | 5,434,676 8.000% |
2,239,159 (+70.07%) |
Filing History |
| 2024-11-14 4:20 pm Sale |
2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Citadel Advisors LLC | 2,737,221 3.900% |
-1,001,261 (-26.78%) |
Filing History |
| 2024-11-14 4:19 pm Sale |
2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN |
Citadel Advisors LLC | 1,158,219 4.200% |
-442,549 (-27.65%) |
Filing History |
| 2024-11-14 4:19 pm Sale |
2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL |
Citadel Advisors LLC | 1,442,489 3.600% |
-719,413 (-33.28%) |
Filing History |